中文 | English
Return
Total: 16 , 1/2
Show Home Prev Next End page: GO
MeSH:(Receptors, Androgen/therapeutic use*)

1.Lineage plasticity-mediated therapy resistance in prostate cancer.

Alexandra M BLEE ; Haojie HUANG

Asian Journal of Andrology 2019;21(3):241-248

2.The androgen receptor in hormone-refractory prostate cancer.

Hai-Lei MAO ; Zhi-Qi ZHU ; Charlie Degui CHEN

Asian Journal of Andrology 2009;11(1):69-73

3.Bipolar androgen therapy: A novel therapeutic strategy for castration-resistant prostate cancer.

Yong-Hui HU ; Jian-Chao GUO ; Meng ZHANG

National Journal of Andrology 2017;23(12):1138-1140

4.FOXA1 in prostate cancer.

Hui-Yu DONG ; Lei DING ; Tian-Ren ZHOU ; Tao YAN ; Jie LI ; Chao LIANG

Asian Journal of Andrology 2023;25(3):287-295

5.Estrogen receptor beta suppresses the androgen receptor oncogenic effects in triple-negative breast cancer.

Feng XU ; Kun XU ; Lingling FAN ; Xintong LI ; Yiqiu LIU ; Fang YANG ; Chengjun ZHU ; Xiaoxiang GUAN

Chinese Medical Journal 2024;137(3):338-349

6.Impact of taxanes on androgen receptor signaling.

Shanshan BAI ; Bryan Y ZHANG ; Yan DONG

Asian Journal of Andrology 2019;21(3):249-252

7.The current status of hormone treatment for prostate cancer patients in Korean real-world practice: a multi-institutional observational study.

Jung Kwon KIM ; Jung Jun KIM ; Taek Won GANG ; Tae Kyun KWON ; Hong Sup KIM ; Seung Chul PARK ; Jae-Shin PARK ; Jong-Yeon PARK ; Seok Joong YOON ; Youn-Soo JEON ; Jin Seon CHO ; Kwan Joong JOO ; Sung-Hoo HONG ; Seok-Soo BYUN

Asian Journal of Andrology 2019;21(2):115-120

8.Proliferative response of human prostate cancer cell to hormone inhibited by androgen receptor antisense RNA.

Jun JIANG ; Luo-fu WANG ; Yu-hua FANG ; Feng-shuo JIN ; Wen-sheng JIN

Chinese Medical Journal 2004;117(5):684-688

9.Effects of extract of Buddleja officinalis eye drops on androgen receptors of lacrimal gland cells of castrated rats with dry eye.

Qing-Hua PENG ; Xiao-Lei YAO ; Quan-Long WU

Chinese Journal of Integrated Traditional and Western Medicine 2012;32(1):72-114

10.Scaffold protein MAPK8IP2 expression is a robust prognostic factor in prostate cancer associated with AR signaling activity.

Jian HUANG ; Wang LIU ; Bi-Yun LIN ; Jean C LI ; Jane LU ; Ben-Yi LI

Asian Journal of Andrology 2023;25(2):198-207

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 16 , 1/2 Show Home Prev Next End page: GO